Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SPFPL THIBAULT VERMOYAL PHARMACIEN : revenue, balance sheet and financial ratios

SPFPL THIBAULT VERMOYAL PHARMACIEN is a French company founded 5 years ago, specialized in the sector Fonds de placement et entités financières similaires. Based in COGNIN (73160), this company of category PME shows in 2024 a net income negative of -4 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SPFPL THIBAULT VERMOYAL PHARMACIEN (SIREN 893873158)
Indicator 2024 2023 2022 2021
Revenue N/C N/C N/C N/C
Net income -3 995 € 50 672 € 50 766 € -42 035 €
EBITDA -1 474 € -1 414 € -967 € -89 113 €
Net margin N/C N/C N/C N/C

Revenue and income statement

In 2024, SPFPL THIBAULT VERMOYAL PHARMACIEN records a net loss of 4 k€. This deficit will reduce equity on the balance sheet.

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-1 474 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-1 474 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-3 995 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 867%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 10%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

866.758%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

10.344%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

-131.064

Solvency indicators evolution
SPFPL THIBAULT VERMOYAL PHARMACIEN

Sector positioning

Debt ratio
866.76 2024
2022
2023
2024
Q1: 0.01
Med: 13.69
Q3: 116.56
Average

In 2024, the debt ratio of SPFPL THIBAULT VERMOYAL P... (866.76) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
10.34% 2024
2022
2023
2024
Q1: 13.95%
Med: 55.8%
Q3: 90.35%
Average

In 2024, the financial autonomy of SPFPL THIBAULT VERMOYAL P... (10.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
-131.06 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.15 years
Q3: 4.69 years
Excellent -50 pts over 3 years

In 2024, the repayment capacity of SPFPL THIBAULT VERMOYAL P... (-131.06) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-171.031

Liquidity indicators evolution
SPFPL THIBAULT VERMOYAL PHARMACIEN

Sector positioning

Interest coverage
-171.03x 2024
2022
2023
2024
Q1: -144.56x
Med: -8.16x
Q3: 0.0x
Average

In 2024, the interest coverage of SPFPL THIBAULT VERMOYAL P... (-171.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Positioning of SPFPL THIBAULT VERMOYAL PHARMACIEN in its sector

Comparison with sector Fonds de placement et entités financières similaires

Similar companies (Fonds de placement et entités financières similaires)

Compare SPFPL THIBAULT VERMOYAL PHARMACIEN with other companies in the same sector:

Voir toutes les statistiques du secteur Fonds de placement et entités financières similaires

Frequently asked questions about SPFPL THIBAULT VERMOYAL PHARMACIEN

What is the revenue of SPFPL THIBAULT VERMOYAL PHARMACIEN ?

The revenue of SPFPL THIBAULT VERMOYAL PHARMACIEN is not publicly disclosed (confidential accounts filed with INPI).

Is SPFPL THIBAULT VERMOYAL PHARMACIEN profitable?

SPFPL THIBAULT VERMOYAL PHARMACIEN recorded a net loss in 2024.

Where is the headquarters of SPFPL THIBAULT VERMOYAL PHARMACIEN ?

The headquarters of SPFPL THIBAULT VERMOYAL PHARMACIEN is located in COGNIN (73160), in the department Savoie.

Where to find the tax return of SPFPL THIBAULT VERMOYAL PHARMACIEN ?

The tax return of SPFPL THIBAULT VERMOYAL PHARMACIEN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SPFPL THIBAULT VERMOYAL PHARMACIEN operate?

SPFPL THIBAULT VERMOYAL PHARMACIEN operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.